-
Views
-
Cite
Cite
N E Borglin, Clinical Evaluation of the Progestational Effect of Allylestrenol, Acta Endocrinologica, Volume 35, Issue 4_Supplement, Dec 1960, Pages NP–S15, https://doi.org/10.1530/acta.0.XXXVS0NP
- Share Icon Share
Abstract
Allylestrenol, a new oral progestational steroid, was studied for its effect on primary and secondary amenorrhoea, anovulation, irregular shedding of the endometrium, premenstrual tension, and threatened or habitual abortion. The progestational effect was good in all of the groups. Allylestrenol is not excreted as pregnanediol in the urine. In the doses used the preparation had no inhibitory effect on the adrenal cortex, the plasma histaminase activity did not increase, and it had no demonstrable androgenic or other side effects.
This content is only available as a PDF.
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://dbpia.nl.go.kr/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
Issue Section:
Articles
You do not currently have access to this article.